Cost-Effectiveness Analysis
A method for comparing the costs and effects of alternatives using a common outcome unit. It examines additional effects relative to additional costs without converting outcomes in natural units into monetary values. [1]
- Difficulty
- Intermediate
- Cost
- Medium
- Duration
- Planning example, not a universal standard duration: 2 weeks–3 months, including outcome data collection and analysis
How it works at a glance
Align costs and effects across the same population, period and perspective. Distinguish the average cost-effectiveness ratio from the incremental cost-effectiveness ratio (ICER), calculated from differences between alternatives. [1]
ICER is the difference in costs divided by the difference in effects. Consider alternatives after checking options that cost more and are less effective, the interpretation of zero or negative differences, and uncertainty in effect estimates. [1]
- Define the comparator
- Select the outcome indicator
- Identify costs
- Collect and analyze effect data
- Calculate CER and ICER
- Compare with thresholds and analyze uncertainty
When to use it and when it is unsuitable
When to use it
- When you want to compare the cost efficiency of interventions or programs pursuing the same goal and select the most efficient approach
- When deciding which interventions should receive priority for limited resources under a budget constraint
- When monetizing outcomes in health care, welfare or education is ethically or politically difficult to accept
- When developing guidelines or using health technology assessment (HTA) to consider adopting a new treatment or intervention
When it is unsuitable
- When comparing programs with different goals. CEA cannot function without a single common outcome indicator; CBA or Value for Money evaluation is more appropriate.
- If different outcomes or equity matter and a single common outcome cannot support a decision, combine outcome-specific findings with multi-criteria judgments.
- When identifying costs is itself difficult, for example because delivery arrangements are complex and cost attribution is unclear
Participants, roles, and deliverables
Participants and roles
Evaluation lead for economic analysis, program staff providing cost data, and a statistician estimating effect sizes. Review by relevant specialists, such as in health care or education, is desirable.
Main deliverables
- Cost and effect data table by alternative
- CER and ICER calculation table
- Sensitivity analysis, including a cost-effectiveness plane and CEAC for probabilistic sensitivity analysis
- Cost-effectiveness analysis report
Implementation steps
- Define the comparatorSpecify the intervention and comparator: no intervention, existing practice or an alternative. Reach agreement carefully, because the choice of comparator decisively affects ICER.
- Select the outcome indicatorDefine a common outcome in natural units and a common period for the alternatives. Check how effects are estimated and the basis for causal interpretation. Analyze different outcomes separately and show their trade-offs.
- Identify costsInclude direct costs, such as personnel, supplies and facilities, and indirect costs, such as beneficiaries' opportunity costs, according to the analytical perspective. Document calculation methods and their basis.
- Collect and analyze effect dataMeasure or estimate outcomes for each alternative. For observational studies, control for confounding and state the limits of causal inference. Check sample size and statistical uncertainty.
- Calculate CER and ICERCalculate incremental costs and effects between alternatives. Consider more costly, less effective options and extended dominance, then interpret ICER among the remaining options. Do not choose solely on the basis of a lower average cost-effectiveness ratio.
- Compare with thresholds and analyze uncertaintyCompare findings with applicable thresholds or value judgments about budgets and outcomes. Report incremental costs and effects even without a threshold, and examine uncertainty through sensitivity analysis. Interpret a negative ICER by returning to the signs of incremental costs and effects.
Strengths and limitations
Strengths
- Not monetizing outcomes makes this approach more ethically acceptable in health care, welfare and education.
- Directly compares alternatives pursuing the same goal and helps prioritize them within a limited budget.
- Avoids monetizing outcomes, but collecting and estimating costs and effects still requires substantial resources.
- ICER is a simple indicator that policy-makers and funders can readily understand.
Limitations
- Programs without a common outcome unit cannot be compared directly using a single ICER.
- Cost-effectiveness thresholds can be arbitrary, and adoption decisions depend heavily on the selected threshold.
- As with CBA, causal attribution remains an issue: whether observed outcomes resulted from the intervention.
- Combining different outcome dimensions, such as health and social participation, into a single indicator loses important information.
Common pitfalls
- An inappropriate ICER comparator or baseline changes the overall conclusion. Doing nothing under current conditions and using the best existing approach produce entirely different ICERs.
- When effect data come from observational studies, findings are often reported with insufficient adjustment for selection bias. Overestimated effects artificially lower ICER.
- Understating costs by omitting implementation costs, such as personnel, training and system development, makes cost-effectiveness appear better.
Conditions of use and evidence
- When comparing alternatives, examine incremental costs and effects between appropriate comparators, not only total cost divided by total effect. [1]
Compare two application support options
A fictional illustrative example comparing options A and B for the same population and period, with additional people completing applications as the effect.
Scroll horizontally to view the table
| Option | Cost | Additional people completing applications | Average cost-effectiveness ratio |
|---|---|---|---|
| A | JPY 100,000 | 10 people | JPY 10,000 per person |
| B | JPY 160,000 | 20 people | JPY 8,000 per person |
| Increment for B relative to A | JPY 60,000 | 10 people | ICER = JPY 6,000 per additional person |
Common errors in judgment
Treating the difference between each option's average ratios as ICER
How to revise
Divide the cost difference by the effect difference.
ReasonICER is not the subtraction of two ratios.
Always adopting the cheaper option even if it has a smaller effect
How to revise
Consider the effect forgone, cost savings and opportunity costs.
ReasonA low cost alone does not establish contribution to the goal.
References and checked sections
- Developing NICE guidelines: Incorporating economic evaluationNational Institute for Health and Care Excellence
- Section consulted
- Presentation of results / incremental approach
- How it relates to the text
- When comparing alternatives, examine incremental costs and effects between appropriate comparators, not only total cost divided by total effect.
Editorial and checking information
How to cite this page
Change history
- — Checked sources for definitions and applicability conditions, and added fictional examples, reasons for judgments and examples for every worksheet field. Revised unverified claims about history and adoption. Also reviewed existing procedures and cautions, and adjusted fixed participant counts and thresholds and generalizations about institutions.


